Biotech · Private company
SanBio, Inc.
Track this companyFree. Adds SanBio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- SB623Phase 2 · Chronic Ischemic StrokeClinicalTrials.gov · fetched Nov 12, 2026
- SB623 cellsPhase 2 · Traumatic Brain InjuryClinicalTrials.gov · fetched Nov 12, 2026
- SB623 Implant (2.5M)Phase 2 · Chronic Ischemic StrokeClinicalTrials.gov · fetched Nov 12, 2026
- SB623 Implant (5.0M)Phase 2 · Chronic Ischemic StrokeClinicalTrials.gov · fetched Nov 12, 2026
- Sham ControlPhase 2 · Traumatic Brain InjuryClinicalTrials.gov · fetched Nov 12, 2026
- Sham surgeryPhase 2 · Chronic Ischemic StrokeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)PHASE2 · COMPLETED · started Jul 6, 2016ClinicalTrials.gov NCT02416492 · fetched Nov 12, 2026
- Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic StrokePHASE2 · COMPLETED · started Mar 8, 2016ClinicalTrials.gov NCT02448641 · fetched Nov 12, 2026
- A Study of Modified Stem Cells in Stable Ischemic StrokePHASE1_PHASE2 · COMPLETED · started Jan 1, 2011ClinicalTrials.gov NCT01287936 · fetched Nov 12, 2026